Skip to content
Use caution Medical device recall · FDA · Published September 24, 2021

Philips Azurion Interventional Fluoroscopy System Software 2.1.x Recall: Table Lock-Up

Philips recalls Azurion Interventional Fluoroscopy systems with software version 2.1.x (model numbers 722063-722228) due to risk of table lock-up when pressing both APC and Float Tabletop buttons simultaneously, potentially causing imaging unavailability.

🇺🇸 FDA recall #Z-0213-2022Medical devicePhilips ›
Take action

Contact the company

Recalling firmPhilips North America Llc222 Jacobs St · Cambridge, MA 02141-2289
✎ GovInfoNow plain-language explainer

What happened, in plain English

Philips is recalling certain Azurion Interventional Fluoroscopy systems with software version 2.1.x (model numbers 722063-722228) because pressing both the APC and Float Tabletop buttons at the same time can cause the table to lock up and stop X-ray imaging. This could lead to incomplete procedures or delays in medical treatments. Read more at govinfonow.com/recall/61752-philips-azurion-interventional-fluoroscopy-system-software-2-1-x-recall.

Source Summary by GovInfoNow · govinfonow.com/recall/61752-philips-azurion-interventional-fluoroscopy-system-software-2-1-x-recall · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0213-2022

Cite this page

“Philips Azurion Interventional Fluoroscopy System Software 2.1.x Recall: Table Lock-Up.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/61752-philips-azurion-interventional-fluoroscopy-system-software-2-1-x-recall. Based on FDA recall #Z-0213-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0213-2022%22&limit=1).

Why it’s dangerous

When the user presses or releases both the APC (accept) button and the Float Tabletop (panning) button at the same time, the system may lock the table in place. This prevents the X-ray imaging from functioning properly during procedures, potentially causing incomplete treatments or delays.

Who’s affected

Healthcare professionals using Philips Azurion Interventional Fluoroscopy systems with software version 2.1.x (model numbers 722063-722228) are affected. The risk is highest for medical staff operating these systems during procedures where precise table movement is critical.

How to tell if you have this one

Check if your Philips Azurion Interventional Fluoroscopy system has software version 2.1.x and model numbers 722063, 722064, 722067, 722068, 722078, 722079, 722221, 722222, 722223, 722224, 722225, 722226, 722227, or 722228. The system also has a unique device identifier (UDI#) listed in the serial numbers provided.

  • Brand
    Philips
  • Product
    Philips Azurion Interventional Fluoroscopic X-Ray System, Software version 2.1.x, Model numbers 722063, 722064, 722067
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Software Version

    Verify your system's software version by checking the device settings or documentation; the affected version is 2.1.x.

  2. Update Software

    Philips will provide a software update to fix the issue; contact Philips support for instructions on how to update.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Domestic distribution nationwide. International distribution worldwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 3 years after the firm started it.

1. Firm started the recall: Sep 24, 202112. FDA classified it Class II: Nov 9, 202123. Published in FDA’s Enforcement Report: Nov 17, 202134. FDA terminated the recall: Sep 26, 2024420212024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0213-2022 (September 24, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0213-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA